Maximum Recommended Dose of Midodrine for Orthostatic Hypotension
The maximum recommended dose of midodrine for treating orthostatic hypotension is 10 mg three times daily, with a total daily maximum of 30 mg. 1
Dosing Guidelines
Standard Dosing
- Starting dose: 10 mg three times daily 1
- Dosing schedule: Approximately 4-hour intervals during daytime hours when upright activity is needed 1
- Suggested timing: morning (upon arising), midday, and late afternoon (not later than 6 PM)
- Alternative interval: Can be given at 3-hour intervals if needed to control symptoms, but not more frequently 1
Dose Adjustments
- Maximum single dose: Single doses as high as 20 mg have been given to patients, but this causes severe and persistent systolic supine hypertension in about 45% of patients 1
- Maximum daily dose: Total daily doses greater than 30 mg have been tolerated by some patients, but their safety and usefulness have not been systematically established 1
- Renal impairment: For patients with abnormal renal function, initiate treatment using 2.5 mg doses and titrate cautiously 1
Administration Considerations
Timing of Administration
- Last dose timing: Should not be given after the evening meal or less than 4 hours before bedtime to reduce the risk of supine hypertension during sleep 1
- Daytime use only: Dosing should take place during daytime hours when the patient needs to be upright for daily activities 1
Monitoring
- Blood pressure monitoring: Supine and standing blood pressure should be regularly monitored 1
- Discontinuation criteria: Administration should be stopped if supine blood pressure increases excessively 1
- Efficacy assessment: Should be continued only in patients who demonstrate symptomatic improvement during initial treatment 1
Clinical Evidence for Efficacy
- A double-blind, dose-response study found that 10 mg of midodrine increased standing systolic blood pressure by approximately 30 mmHg at 1 hour, with effects partially sustained for 2 hours 1, 2
- The 10 mg dose demonstrated significant improvement in orthostatic symptoms including dizziness, lightheadedness, weakness, and fatigue compared to placebo 3
- In patients with neurogenic orthostatic hypotension, midodrine at 10 mg three times daily resulted in a 27% (22 mmHg) increase in standing systolic blood pressure 4
Special Considerations
Hepatorenal Syndrome
- In patients with hepatorenal syndrome, midodrine has been used in combination with octreotide and albumin, with midodrine titrated up to a maximum of 12.5 mg orally three times per day 5
Potential Side Effects
- Common side effects: Piloerection, scalp itching/tingling, nausea, urinary urgency, headache 6
- Major concern: Supine hypertension (occurs in up to 25% of patients) 6
- Contraindications: Should not be used in patients with acute kidney injury with serum creatinine ≥5 mg/dL 6
Practical Application
- Start with 10 mg three times daily during daytime hours
- Space doses at least 3-4 hours apart
- Administer last dose no later than 6 PM
- Monitor both supine and standing blood pressure regularly
- Discontinue if excessive supine hypertension develops
- For patients with renal impairment, start at 2.5 mg and titrate cautiously
- Do not exceed 30 mg total daily dose
Remember that midodrine is a prodrug that forms the active metabolite desglymidodrine, which has a half-life of 3-4 hours, explaining the need for multiple daily dosing 1.